Manuel Modiano

10.4k total citations · 1 hit paper
87 papers, 7.0k citations indexed

About

Manuel Modiano is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Manuel Modiano has authored 87 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 30 papers in Pulmonary and Respiratory Medicine and 19 papers in Molecular Biology. Recurrent topics in Manuel Modiano's work include Cancer Treatment and Pharmacology (20 papers), Lung Cancer Treatments and Mutations (16 papers) and Colorectal Cancer Treatments and Studies (14 papers). Manuel Modiano is often cited by papers focused on Cancer Treatment and Pharmacology (20 papers), Lung Cancer Treatments and Mutations (16 papers) and Colorectal Cancer Treatments and Studies (14 papers). Manuel Modiano collaborates with scholars based in United States, Canada and Germany. Manuel Modiano's co-authors include Mace L. Rothenberg, Peter G. Tarassoff, Ryan Nelson, Daniel D. Von Hoff, Anna Maria Storniolo, Malcolm J. Moore, Russell K. Portenoy, John Sahl Andersen, Connie Stephens and M. Christine Cripps and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Manuel Modiano

87 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

1997 4.6k citations Manuel Modiano et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Manuel Modiano United States	25	5.0k	1.8k	1.7k	1.6k	1.4k	87	7.0k
Peter G. Tarassoff United States	15	5.7k 1.1×	1.8k 1.0×	1.9k 1.1×	1.5k 0.9×	1.3k 0.9×	20	7.1k
F. Andrew Dorr United States	25	4.8k 1.0×	2.6k 1.4×	1.8k 1.1×	2.0k 1.3×	1.4k 1.0×	48	8.0k
Mark M. Zalupski United States	43	4.9k 1.0×	2.4k 1.3×	1.4k 0.8×	1.4k 0.9×	1.6k 1.2×	197	6.9k
Connie Stephens United States	7	3.9k 0.8×	1.1k 0.6×	1.4k 0.8×	1.0k 0.6×	957 0.7×	9	4.9k
M. Christine Cripps Canada	12	4.5k 0.9×	1.3k 0.7×	1.5k 0.9×	1.1k 0.7×	1.0k 0.8×	26	5.5k
Peter Harper United Kingdom	45	4.7k 0.9×	3.2k 1.7×	867 0.5×	1.4k 0.9×	1.9k 1.4×	139	7.7k
Daniel Hochhauser United Kingdom	43	4.5k 0.9×	1.4k 0.8×	1.5k 0.9×	2.7k 1.7×	1.0k 0.7×	153	7.4k
Rossana Berardi Italy	45	4.2k 0.8×	2.8k 1.5×	1.4k 0.8×	1.9k 1.2×	1.1k 0.8×	344	7.4k
Margaret A. Tempero United States	45	6.7k 1.3×	1.9k 1.0×	2.6k 1.5×	2.5k 1.6×	2.3k 1.7×	195	11.3k
Young Suk Park South Korea	41	4.0k 0.8×	2.3k 1.2×	1.1k 0.7×	1.3k 0.8×	1.9k 1.4×	227	6.3k

Countries citing papers authored by Manuel Modiano

Since Specialization

Citations

This map shows the geographic impact of Manuel Modiano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Modiano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Modiano more than expected).

Fields of papers citing papers by Manuel Modiano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Modiano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Modiano. The network helps show where Manuel Modiano may publish in the future.

Co-authorship network of co-authors of Manuel Modiano

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Modiano. A scholar is included among the top collaborators of Manuel Modiano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Modiano. Manuel Modiano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kaufman, Jonathan L., Myo Htut, Manish Agrawal, et al.. (2021). Filanesib plus bortezomib and dexamethasone in relapsed/refractory t(11;14) and 1q21 gain multiple myeloma. Cancer Medicine. 11(2). 358–370. 11 indexed citations

Langer, Corey J., Edward S. Kim, Eric Anderson, et al.. (2018). nab-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC. Frontiers in Oncology. 8. 262–262. 7 indexed citations

Petrylak, Daniel P., Nicholas J. Vogelzang, Mark T. Fleming, et al.. (2015). MP82-09 PROSTATE SPECIFIC MEMBRANE ANTIGEN ANTIBODY DRUG CONJUGATE (PSMA ADC) IN PATIENTS (PTS) WITH PROGRESSIVE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) FOLLOWING ABIRATERONE AND/OR ENZALUTAMIDE (ABI/ENZ): RESULTS FROM A PHASE 2 STUDY. The Journal of Urology. 193(4S). 3 indexed citations

Schwartzberg, Lee S., Manuel Modiano, Bernardo L. Rapoport, et al.. (2015). Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial. The Lancet Oncology. 16(9). 1071–1078. 119 indexed citations

Zinner, Ralph, Coleman K. Obasaju, David R. Spigel, et al.. (2014). PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed + Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel + Carboplatin + Bevacizumab Followed by Maintenance Bevacizumab in Patients ith Advanced Nonsquamous Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 10(1). 134–142. 120 indexed citations

Sequist, Lecia V., Manuel Modiano, Olivier Rixe, et al.. (2011). Abstract C27: Targeting ErbB3 and EGFR in lung cancer patients: A phase I trial of MM-121 in combination with erlotinib in patients with non-small cell lung cancer (NSCLC).. Molecular Cancer Therapeutics. 10(11_Supplement). C27–C27. 1 indexed citations

Liebmann, James E., Manuel Modiano, Gary I. Cohen, et al.. (2011). Pixantrone dimaleate in combination with fludarabine, dexamethasone, and rituximab in patients with relapsed or refractory indolent non‐Hodgkin lymphoma. Cancer. 117(22). 5067–5073. 16 indexed citations

Martín, Miguel, John R. Mackey, Tadeusz Pieńkowski, et al.. (2010). Abstract S4-3: Ten-Year Follow-Up Analysis of the BICRG 001 Trial Confirms Superior DFS and OS Benefit of Adjuvant TAC (Docetaxel, Doxorubicin, Cyclophosphamide) over FAC (fluorouracil, Doxorubicin, Cyclophosphamide) in Women with Operable Node-Positive Breast Cancer. Cancer Research. 70(24_Supplement). S4–3. 2 indexed citations

Lim, Soon Thye, Luis Fayad, Anil Tulpule, et al.. (2007). A phase I/II trial of pixantrone (BBR2778), methylprednisolone, cisplatin, and cytosine arabinoside (PSHAP) in relapsed/refractory aggressive non-Hodgkin's lymphoma. Leukemia & lymphoma. 48(2). 374–380. 23 indexed citations

10.

Estes, Jacob M., Charles A. Leath, Manuel Modiano, et al.. (2006). Efficacy and toxicity of the novel chemotherapeutic agent KW-2170 in recurrent epithelial ovarian cancer. Gynecologic Oncology. 102(2). 338–342. 3 indexed citations

11.

Hansen, Lisa, Polly Feigl, Manuel Modiano, et al.. (2005). An Educational Program to Increase Cervical and Breast Cancer Screening in Hispanic Women. Cancer Nursing. 28(1). 47–53. 81 indexed citations

12.

Blanke, Charles D., Jeffrey Shultz, James D. Cox, et al.. (2002). A double-blind placebo-controlled randomized phase III trial of 5-fluorouracil and leucovorin, plus or minus trimetrexate, in previously untreated patients with advanced colorectal cancer. Annals of Oncology. 13(1). 87–91. 24 indexed citations

13.

Feun, Lynn G., Manuel Modiano, King Lee, et al.. (2002). Phase I and pharmacokinetic study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) using a single intravenous dose schedule. Cancer Chemotherapy and Pharmacology. 50(3). 223–229. 108 indexed citations

14.

Belani, Chandra P., Rafat Ansari, JN Atkins, et al.. (2000). A phase III randomized study of carboplatin and paclitaxel with or without amifostine in patients with non-small cell lung cancer (NSCLC). Lung Cancer. 29(1). 22–22. 1 indexed citations

15.

Macdonald, John S., Joth Jacobson, Manuel Modiano, et al.. (2000). A Phase II Trial of Etoposide, Leucovorin, 5-FU, and Interferon Alpha 2b (ELFI) + G-CSF for Patients with Pancreatic Adenocarcinoma: a Southwest Oncology Group Study (SWOG 9413). Investigational New Drugs. 18(3). 269–273. 15 indexed citations

16.

Leichman, Cynthia G., Manuel Modiano, John R. Daniels, et al.. (1999). Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma. Cancer. 86(5). 775–781. 26 indexed citations

17.

Bertoli, Luigi F., Peter D. Eisenberg, Patricia M. Plezia, et al.. (1996). Antiemetic Efficacy of Two Different Single Intravenous Doses of Dolasetron in Patients Receiving High-Dose Cisplatin-Containing Chemotherapy. American Journal of Clinical Oncology. 19(6). 619–623. 21 indexed citations

18.

Modiano, Manuel, et al.. (1996). Evaluation of race as a prognostic factor in multiple myeloma. An ancillary of Southwest Oncology Group Study 8229.. Journal of Clinical Oncology. 14(3). 974–977. 29 indexed citations

19.

Longman, Alice J., Michelle A. Saint‐Germain, & Manuel Modiano. (1992). Use of Breast Cancer Screening by Older Hispanic Women. Public Health Nursing. 9(2). 118–124. 26 indexed citations

20.

Modiano, Manuel, et al.. (1990). Ocular Toxic Effects of Fenretinide. JNCI Journal of the National Cancer Institute. 82(12). 1063–1063. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact